U.S. buys another 100M doses of Pfizer-BioNTech coronavirus vaccine

Pfizer and its German partner BioNTech will supply 100 million more doses of their coronavirus vaccine to the United States by this summer after protracted negotiations over how much the companies could deliver, given their commitments to other nations.

The $1.95 billion agreement doubles the overall U.S. order for the vaccine to 200 million doses. Pfizer and BioNTech said they can supply 70 million doses by June 30, 2021, with the remaining 30 million doses delivered by the end of July.